What is Elevance Health?
Health insurance and services company with >$190B of 2025 revenue and enterprise healthcare scale.
- Category
- Health insurance and services
- Headquarters
- Indianapolis, IN
- Founded
- 1944
- Employees
- 104,000+
- Total funding
- Public company; no VC funding
- Status
- NYSE: ELV; ~$80B market cap
What is Elevance Health?
Elevance Health is a public health insurance and services company headquartered in Indianapolis, IN. It reported >$190B of 2025 revenue and operates at global enterprise scale.
Elevance Health operates in health insurance and services with a portfolio spanning Health Benefits and Carelon. The company reported >$190B of 2025 revenue, employs about 104,000+, and trades as NYSE: ELV. Its customer base is large, regulated, and relationship-driven, with purchasing decisions shaped by clinical outcomes, compliance, reimbursement, operating leverage, and long-term supply reliability.
The company's scale comes from durable demand in healthcare, recurring consumables or services, installed bases, payer or provider relationships, and disciplined capital allocation. Unlike early-stage software companies, Elevance Health is evaluated through revenue growth, margins, cash flow, reimbursement exposure, procedure or prescription volume, quality, and regulatory execution.
For sellers, Elevance Health is not a single buying center. The practical map includes procurement, finance, clinical, IT, security, compliance, operations, supply chain, commercial teams, and business-unit executives. Strong pitches connect directly to patient outcomes, cost-to-serve, risk reduction, revenue capture, uptime, or measurable productivity.
What does Elevance Health offer?
Elevance Health offers healthcare products and services across Health Benefits and Carelon.
- Commercial health benefits· Insurance
- Medicaid· Government
- Medicare Advantage· Government
- CarelonRx· Pharmacy services
- Carelon Services· Health services
- Behavioral health· Care services
- Analytics and payment integrity· Carelon
How does Elevance Health make money?
Elevance earns premium revenue from health plans and fee/service revenue from pharmacy, care, analytics, behavioral, and administrative services.
Elevance earns premium revenue from health plans and fee/service revenue from pharmacy, care, analytics, behavioral, and administrative services. In 2025, that model produced >$190B of revenue, showing the scale of the installed base, service footprint, payer/provider contracts, or distribution volume behind the business.
Pricing is actuarial, risk-score, employer-contract, state-contract, CMS-bid, pharmacy-contract, and service-fee driven; products are sold through benefits contracts rather than public software tiers. That makes the relevant "pricing tier" for sellers an enterprise contracting motion: account segmentation, compliance review, value analysis, legal terms, security review, reimbursement impact, and multi-year renewal economics.
Growth is driven by a mix of market expansion, procedure or prescription volume, product launches, acquisitions, geographic reach, contract renewals, operational efficiency, and technology adoption. Vendors should expect rigorous procurement, documented ROI, data-security requirements, and evidence that the product can work inside regulated healthcare operations.
Who leads Elevance Health?
Elevance Health is led by Gail K. Boudreaux, with finance, operations, clinical, technology, and business-unit leaders shaping major enterprise decisions.
- Gail K. BoudreauxPresident and Chief Executive OfficerCEO since 2017Leads the insurer and Carelon health-services strategy.
- Mark KayeExecutive Vice President and Chief Financial OfficerCFO since 2023; Carelon oversight added in 2026Finance leader with expanded Carelon responsibility.
- Felicia NorwoodExecutive Vice President and President, Health BenefitsExpanded role in 2026Leads consolidated health-benefits operations.
- Kristy DuffeyPresident, Carelon HealthCarelon leadershipSenior leader in care delivery and clinical services.
How do you contact Elevance Health's leadership?
Elevance Health publishes investor-relations, media, supplier, customer, and compliance channels, but it does not publish verified personal executive emails for the listed leaders. Use the public investor-relations route (ir@elevancehealth.com) or official contact forms rather than guessed personal addresses.
ir@elevancehealth.com is a public investor/contact route; personal executive email format not verifiedHow much funding has Elevance Health raised?
Elevance Health is a mature public company, not a venture-backed startup. It trades as NYSE: ELV, had an approximate ~$80B market capitalization in June 2026, and funds growth through operating cash flow, debt markets, public equity access, and acquisition capacity.
Elevance Health's capital history is a public-company story rather than a disclosed venture-round history. The relevant milestones are founding in 1944, public-market access, acquisitions, debt capacity, dividends or buybacks where applicable, and reinvestment in regulated healthcare capabilities.
The company reported >$190B of 2025 revenue and operates with the financing tools expected of a large public healthcare company. Capital is directed toward product development, clinical evidence, facilities, inventory, technology, acquisitions, compliance, reimbursement capabilities, and shareholder returns depending on the business model.
Seller signal: Elevance Health has meaningful buying power, but budget access is tied to risk, ROI, compliance, and executive sponsorship. Vendors should map proposals to cost reduction, growth, care quality, automation, supply resilience, cybersecurity, data quality, or measurable operating improvement.
How did Elevance Health get here?
Elevance Health grew through founding, public-market scale, product expansion, acquisitions, and healthcare-market execution.
- 1944Blue Cross predecessor rootsThe organization traces roots to Blue Cross/Blue Shield plans.
- 2001Anthem demutualizesThe company becomes a public managed-care platform.
- 2014Amerigroup integrationMedicaid becomes a major growth platform.
- 2022Rebrands as Elevance HealthThe company shifts identity beyond insurance.
- 202545.2M medical membersElevance reports medical membership at year-end 2025.
- 2026Carelon management changesCFO Mark Kaye adds Carelon oversight in a simplification move.
Who are Elevance Health's competitors?
Elevance Health competes with companies that overlap in customers, budgets, clinical categories, distribution channels, or healthcare services.
- UnitedHealth GroupLargest managed-care and Optum health-services competitor.
- The Cigna GroupCommercial, PBM, specialty, and employer-health competitor.
- CVS HealthAetna insurance, PBM, pharmacy, and care-delivery competitor.
- HumanaMedicare Advantage and CenterWell care-services competitor.
- CenteneMedicaid, Marketplace, and government-plan competitor.
Elevance Health — frequently asked questions
